The effect of pertussis whole cell and acellular vaccines on pulmonary immunology in an aerosol challenge model

Cellular Immunology

Volumn 227, Issue 1, 2004, Pages 51-58

  Carter, Clive R D ^a   Dagg, Belinda M ^a   Whitmore, Katie M ^a   Keeble, James R ^a   Asokanathan, Cathy ^a   Xing, Dorothy ^a   Walker, K Barry ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Acellular vaccine; Cytokines; Pertussis; Protection; Pulmonary immunology; Vaccination; Whole cell vaccine

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE; PHOSPHATE; UNCLASSIFIED DRUG; VACCINE; WHOLE CELL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BORDETELLA PERTUSSIS; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE EXPRESSION; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; TH1 CELL; VACCINATION;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANTIGENS, CD3; BORDETELLA PERTUSSIS; CELLS, CULTURED; FEMALE; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED STRAINS; PERTUSSIS VACCINE; RESPIRATORY SYSTEM; RNA, MESSENGER; TH1 CELLS; VACCINES, ACELLULAR; WHOOPING COUGH;

BACTERIA (MICROORGANISMS); BORDETELLA; BORDETELLA PERTUSSIS; MURINAE;

EID: 1642356236     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2003.12.001     Document Type: Article

References (29)

1. Ivanoff B., Robertson S.E. Pertussis: a worldwide problem. Dev. Biol. Stand. 89:1997;3-13.
2. Galazka A. Control of pertussis in the world. World Health Stat. Q. 45:1992;238-247.
3. Cherry J.D., Gornbein J., Heininger U., Stehr K. A search for serological correlates of immunity to Bordetella pertussis cough illnesses. Vaccine. 16:1998;1901-1906.
4. Cherry J.D. Epidemilogical, clinical and laboratory aspects of pertussis in adults. Clin. Infect. Dis. 28(Suppl. 2):1999;S112-S117.
5. Jenkinson D. Duration of effectiveness of pertussis: evidence from a 10 year community study. Br. Med. J. (Clin. Res. Ed.). 296:1998;612-615.
6. Aoyama T., Harashima M., Nishimura K., Saito Y. Outbreak of pertussis in highly immunised adolescents and its secondary spread to their families. Acta Paediatr. Jpn. 37:1995;321-324.
7. von Konig C.H., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect. Dis. 2:2002;744-750.
8. Sato H., Sato Y. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect. Immun. 46:1984;415-421.
9. Simondon F., Preziosi M.P., Yam A., Cane C.T., Chabirand L., Iteman I., Sanden G., Mboup S., Hoffenbach A., Knudsen J., Guisso N., Wassilak S., Cadoz M. A randomised double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine. 15:1997;1606-1612.
10. Storsaeter J., Hallender H.O., Gustafsson L., Olin P. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine. 16:1998;1907-1917.
11. Leef M., Elkins J.L., Barbic J., Shahin R.D. Protective immunity to Bordetella pertussis requires both B cells and CD4(+) T cells for key functions other than specific antibody production. J. Exp. Med. 191:2000;2087-2091.
12. Mahon B.P., Brady M.T., Mills K.H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody implications for long term immunity in children. J. Infect. Dis. 181:2000;2087-2091.
13. Mills K.H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th-1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:1993;399-410.
14. Friedman R.I., Nordensson K., Wilson L., Akporiiaye E.T., Yocum D.E. Uptake and intracellular survival of Bordetella pertussis in human macrophages. Infect. Immun. 60:1992;4578-4585.
15. Cheers C., Gray D.F. Macrophage behaviour during complaisant phase of murine pertussis. Immunity. 17:1969;875-887.
16. Xing D.K., Canthaboo C., Corbel M.J. Nitric oxide induction in murine macrophages and spleen cells by whole cells Bordetella pertussis vaccine. Vaccine. 16:1998;16-23.
17. Canthaboo C., Xing D.K., Wei X.Q., Corbell M.K. investigation of role of nitric oxide in protection from Bordetella pertussis respiratory challenge. Infect. Immun. 70:2002;679-684.
18. Redhead K., Watkins J., Barnard A., Mills K.H. Effective immunisation against Bordetella pertussis respiratory infection in mice in dependent on induction of cell-mediated immunity. Infect. Immun. 61:1993;3190-3198.
19. Mills K.H., Ryan M., Ryan E., Mahon B.P. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:1998;594-602.
20. Feng C.G., Bean A.G., Hooi H., Briscoe H., Britton W.J. Increase in gamma interferon secreting CD8(+) as well as CD4(+) T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:1999;3242-3247.
21. Wadhwa M., Bird C., Dilger P., Mire-Sluis A., Thorpe R. Quantitative biological assays for individual cytokines. Balkwell F. Cytokine Cell biology, A Practical Approach. 2000;207-212 Oxford University Press, Oxford.
22. Barnard A., Mahon B.P., Watkins J., Redhead K., Mills K.H. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T cell subsets as Th1, Th2 or Th0. Immunology. 87:1996;372-380.
23. Ryan M., Gothefors L., Storsaeter J., Mills K.H. Bordetella pertussis specfic Th1/Th2 cells generated following respiratory infection or immunisation with an acellular vaccine: comparison of the T cell profiles in infants and mice. Dev. Biol. Stand. 89:1997;297-305.
24. He Q., Minh N.N., Edelman K., Viljanen M.K., Arvilommi H., Mertsola J. Cytokine mRNA expression and proliferative responses induced by pertussis toxin, filamentous hemagglutinin and pertactin of Bordetella pertussis in the peripheral blood mononuclear cells of infected and immunised schoolchildren and adults. Infect. Immun. 66:1998;3796-3801.
25. Ryan E.J., Nilsson L., Kjellman N., Gothefors L., Mills K.H. Booster immunisation of children with an acellular pertussis vaccine enhances Th-2 cytokine production and serum IGE responses against pertussis toxin but not against common allergens. Clin. Exp. Immunol. 121:2000;193-200.
26. Mahon B.P., Ryan M.S., Griffin F., Mills K.H. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting the induction of Th-1 cells. Infect. Immun. 64:1996;5295-5301.
27. Mahon B.P., Sheahan B.J., Griffin F., Murphy G., Mills K.G. Atypical disease after Bordetella pertussis respiratory infection in mice with targeted disruptions of interferon-γ receptor or immunoglobulin μ chain genes. J. Exp. Med. 186:1997;1843-1851.
28. Barbic J., Leef M.F., Burs D.L., Shahin R.D. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect. Immun. 65:1997;4904-4908.
29. Canthaboo C., Williams L., Xing D.L., Corbel M.J. Investigation of cellular and humoral immune responses to whole cell and acellular pertussis vaccines. Vaccine. 19:2000;637-643.